Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Puentes, Fabiola ^a   van der Star, Baukje J ^b,c   Victor, Marion ^d   Kipp, Markus ^d   Beyer, Cordian ^d   Peferoen Baert, Regina ^b,c   Ummenthum, Kimberley ^b,c   Pryce, Gareth ^a   Gerritsen, Wouter ^b,c   Huizinga, Ruth ^e   Reijerkerk, Arie ^b,c   van der Valk, Paul ^b,c   Baker, David ^a   Amor, Sandra ^a,b,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c De Boelelaan 1105   (Netherlands)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Axonal damage; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Neurodegeneration; Neurofilament light

Indexed keywords

EPITOPE; GRANZYME B; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEUROFILAMENT LIGHT PROTEIN; NEUROFILAMENT PROTEIN; PERFORIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; MALE; MOUSE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; SPASTICITY;

ANIMALS; AUTOANTIGENS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICROSCOPY, CONFOCAL; NEUROFILAMENT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; T-LYMPHOCYTES;

EID: 84884315101     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-118     Document Type: Article

References (43)

1. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 1986, 19:578-587. 10.1002/ana.410190610, 3524414.
2. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 2010, 162:1-11. 10.1111/j.1365-2249.2010.04143.x, 2990924, 20682002.
3. van Noort JM, Bsibsi M, Gerritsen WH, van der Valk P, Bajramovic JJ, Steinman L, Amor S. Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. J Neuropathol Exp Neurol 2010, 69:694-703. 10.1097/NEN.0b013e3181e4939c, 20535035.
4. Huizinga R, Hintzen RQ, Assink K, van Meurs M, Amor S. T-cell responses to neurofilament light protein are part of the normal immune repertoire. Int Immunol 2009, 21:433-441. 10.1093/intimm/dxp011, 19240089.
5. Iorio R, Lennon VA. Neural antigen-specific autoimmune disorders. Immunol Rev 2012, 248:104-121. 10.1111/j.1600-065X.2012.01144.x, 22725957.
6. Zhang Y, Da RR, Guo W, Ren HM, Hilgenberg LG, Sobel RA, Tourtellotte WW, Smith MA, Olek M, Gupta S, Robertson RT, Nagra R, Van Den Noort S, Qin Y. Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis. J Clin Immunol 2005, 25:254-264. 10.1007/s10875-005-4083-5, 15981091.
7. Huizinga R, Heijmans N, Schubert P, Gschmeissner S, Hart BA T, Herrmann H, Amor S. Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice. J Neuropathol Exp Neurol 2007, 66:295-304. 10.1097/nen.0b013e318040ad5c, 17413320.
8. Huizinga R, Gerritsen W, Heijmans N, Amor S. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Neurobiol Dis 2008, 32:461-470. 10.1016/j.nbd.2008.08.009, 18804534.
9. Beltran E, Hernandez A, Lafuente EM, Coret F, Simo-Castello M, Bosca I, Perez-Miralles FC, Burgal M, Casanova B. Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis. J Neuroimmunol 2012, 247:63-69. 10.1016/j.jneuroim.2012.03.013, 22498100.
10. Derfuss T, Parikh K, Velhin S, Braun M, Mathey E, Krumbholz M, Kumpfel T, Moldenhauer A, Rader C, Sonderegger P, Pöllmann W, Tiefenthaller C, Bauer J, Lassmann H, Wekerle H, Karagogeos D, Hohlfeld R, Linington C, Meinl E. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc Natl Acad Sci U S A 2009, 106:8302-8307. 10.1073/pnas.0901496106, 2688870, 19416878.
11. Hoftberger R, Aboul-Enein F, Brueck W, Lucchinetti C, Rodriguez M, Schmidbauer M, Jellinger K, Lassmann H. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol 2004, 14:43-50.
12. Gobel K, Melzer N, Herrmann AM, Schuhmann MK, Bittner S, Ip CW, Hunig T, Meuth SG, Wiendl H. Collateral neuronal apoptosis in CNS gray matter during an oligodendrocyte-directed CD8(+) T cell attack. Glia 2010, 58:469-480.
13. Werner P, Pitt D, Raine CS. Glutamate excitotoxicity - a mechanism for axonal damage and oligodendrocyte death in multiple sclerosis?. J Neural Transm Suppl 2000, 375-385.
14. Woodroofe MN. Cytokine production in the central nervous system. Neurology 1995, 45:S6-S10.
15. Witherick J, Wilkins A, Scolding N, Kemp K. Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. Autoimmune Dis 2010, 2011:164608. 3010615, 21197107.
16. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130:1089-1104.
17. Huizinga R, van der Star BJ, Kipp M, Jong R, Gerritsen W, Clarner T, Puentes F, Dijkstra CD, van der Valk P, Amor S. Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis. Glia 2012, 60:422-431. 10.1002/glia.22276, 22161990.
18. Al-Izki S, Pryce G, O'Neill JK, Butter C, Giovannoni G, Amor S, Baker D. Practical guide to the mouse induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH. Mult Scler Relat Disord 2012, 1:29-38.
19. Amor S, O'Neill JK, Morris MM, Smith RM, Wraith DC, Groome N, Travers PJ, Baker D. Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif. J Immunol 1996, 156:3000-3008.
20. Rankpep [http://imed.med.ucm.es/Tools/rankpep.html].
21. Image J. http://rsb.info.nih.gov/ij/index.html].
22. Braun A, Dang J, Johann S, Beyer C, Kipp M. Selective regulation of growth factor expression in cultured cortical astrocytes by neuro-pathological toxins. Neurochem Int 2009, 55:610-618. 10.1016/j.neuint.2009.06.004, 19524632.
23. Butter C, O'Neill JK, Baker D, Gschmeissner SE, Turk JL. An immunoelectron microscopical study of the expression of class II major histocompatibility complex during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice. J Neuroimmunol 1991, 33:37-42. 10.1016/0165-5728(91)90032-3, 2056070.
24. BCPred [http://ailab.cs.iastate.edu/bcpreds/], BCPred.
25. Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, Schramm J, Elger CE, Lassmann H. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002, 51:311-318. 10.1002/ana.10100, 11891826.
26. D'Andrea MR. Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res 2003, 982:19-30. 10.1016/S0006-8993(03)02881-6, 12915236.
27. Benkler M, Agmon-Levin N, Hassin-Baer S, Cohen OS, Ortega-Hernandez OD, Levy A, Moscavitch SD, Szyper-Kravitz M, Damianovich M, Blank M, Chapman J, Shoenfeld Y. Immunology, autoimmunity, and autoantibodies in Parkinson's disease. Clin Rev Allergy Immunol 2012, 42:164-171. 10.1007/s12016-010-8242-y, 21234712.
28. Neumann H, Cavalie A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science 1995, 269:549-552. 10.1126/science.7624779, 7624779.
29. Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, Lassmann H, Dornmair K, Kurschus FC, Liblau RS, Wekerle H. Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med 2009, 15:626-632. 10.1038/nm.1975, 19483694.
30. Giuliani F, Goodyer CG, Antel JP, Yong VW. Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol 2003, 171:368-379.
31. Meuth SG, Herrmann AM, Simon OJ, Siffrin V, Melzer N, Bittner S, Meuth P, Langer HF, Hallermann S, Boldakowa N, Herz J, Munsch T, Landgraf P, Aktas O, Heckmann M, Lessmann V, Budde T, Kieseier BC, Zipp F, Wiendl H. Cytotoxic CD8+ T cell-neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death. J Neurosci 2009, 29:15397-15409. 10.1523/JNEUROSCI.4339-09.2009, 20007464.
32. Miller N, Shriver LP, Bodiga VL, Ray A, Basu S, Ahuja R, Jana A, Pahan K, Dittel BN. Lymphocytes with cytotoxic activity induce rapid microtubule axonal destabilization independently and before signs of neuronal death. ASN Neuro 2013, 5:e00105. 3565378, 23289514.
33. Zaguia F, Saikali P, Ludwin S, Newcombe J, Beauseigle D, McCrea E, Duquette P, Prat A, Antel JP, Arbour N. Cytotoxic NKG2C + CD4 T cells target oligodendrocytes in multiple sclerosis. J Immunol 2013, 190:2510-2518. 10.4049/jimmunol.1202725, 23396942.
34. Zangi L, Zlotnikov Klionsky Y, Yarimi L, Bachar-Lustig E, Eidelstein Y, Shezen E, Hagin D, Ito Y, Takai T, Reich-Zeliger S, Lask A, Milstein O, Jung S, Shinder V, Reisner Y. Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7. Blood 2012, 120:1647-1657. 10.1182/blood-2012-02-410803, 22776817.
35. Allen SJ, Baker D, O'Neill JK, Davison AN, Turk JL. Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Cell Immunol 1993, 146:335-350. 10.1006/cimm.1993.1031, 8174174.
36. Silber E, Semra YK, Gregson NA, Sharief MK. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 2002, 58:1372-1381. 10.1212/WNL.58.9.1372, 12011283.
37. Pryce G, O'Neill JK, Croxford JL, Amor S, Hankey DJ, East E, Giovannoni G, Baker D. Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis. J Neuroimmunol 2005, 165:41-52. 10.1016/j.jneuroim.2005.04.009, 15939483.
38. Smith PA, Morris-Downes M, Heijmans N, Pryce G, Arter E, O'Neill JK, Hart TB, Baker D, Amor S. Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice. J Neuroimmunol 2005, 164:76-84. 10.1016/j.jneuroim.2005.04.006, 15927270.
39. Liu GY, Baker D, Fairchild S, Figueroa F, Quartey-Papafio R, Tone M, Healey D, Cooke A, Turk JL, Wraith DC. Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules. Immunogenetics 1993, 37:296-300.
40. Miller A, Al-Sabbagh A, Santos LM, Das MP, Weiner HL. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 1993, 151:7307-7315.
41. Fressinaud C, Eyer J. Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro. Neurochem Int 2012, 62:306-313.
42. Thoua NM, van Noort JM, Baker D, Bose A, van Sechel AC, van Stipdonk MJ, Travers PJ, Amor S. Encephalitogenic and immunogenic potential of the stress protein alphaB-crystallin in Biozzi ABH (H-2A(g7)) mice. J Neuroimmunol 2000, 104:47-57. 10.1016/S0165-5728(99)00246-5, 10683514.
43. Bar-Or A, Vollmer T, Antel J, Arnold DL, Bodner CA, Campagnolo D, Gianettoni J, Jalili F, Kachuck N, Lapierre Y, Niino M, Oger J, Price M, Rhodes S, Robinson WH, Shi FD, Utz PJ, Valone F, Weiner L, Steinman L, Garren H. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Arch Neurol 2007, 64:1407-1415. 10.1001/archneur.64.10.nct70002, 17698695.